West Nile assay
This article was originally published in The Gray Sheet
Chiron and Gen-Probe expect to file with FDA in early 2005 for their jointly developed West Nile virus blood donation screening assay for the Procleix Tigris automated nucleic acid testing system. The firms announced launch of an IND trial for the assay Sept. 1. The system will be tested in epidemic areas in Arizona, California, Colorado, Florida and Oklahoma to "improve the efficiency of high volume testing," they say (1"The Gray Sheet" Aug. 4, 2003, p. 21)...
You may also be interested in...
Gen-Probe projects a U.S. market launch in the first half of 2004 for its Tigris DTS fully automated, high-throughput molecular diagnostic instrument system
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.